169 related articles for article (PubMed ID: 32292915)
1. The Imperfect Cytokine Storm: Severe COVID-19 With ARDS in a Patient on Durable LVAD Support.
Chau VQ; Oliveros E; Mahmood K; Singhvi A; Lala A; Moss N; Gidwani U; Mancini DM; Pinney SP; Parikh A
JACC Case Rep; 2020 Jul; 2(9):1315-1320. PubMed ID: 32292915
[TBL] [Abstract][Full Text] [Related]
2. Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration.
Chen R; Lan Z; Ye J; Pang L; Liu Y; Wu W; Qin X; Guo Y; Zhang P
Front Immunol; 2021; 12():589095. PubMed ID: 33995341
[TBL] [Abstract][Full Text] [Related]
3. Tocilizumab as a Treatment for 'Cytokine Storm Syndrome' in COVID-19: A Case Report.
Syam AF; Pitoyo CW; Suhendro S; Zulkarnain B; Indrasari ND; Aditianingsih D; Irawan C; Susilo A; Rumende CM; Wijaya IP; Ibrahim F; Rasmin M; Alwi I; Makmun D
Acta Med Indones; 2021 Apr; 53(2):194-201. PubMed ID: 34251348
[TBL] [Abstract][Full Text] [Related]
4. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 ARDS in two patients with left ventricular assist device.
Özgür MM; Hançer H; Altaş Ö; Kırali K
J Artif Organs; 2022 Jun; 25(2):148-154. PubMed ID: 34333741
[TBL] [Abstract][Full Text] [Related]
6. Severe Acute Respiratory Syndrome Coronavirus-2 Induces Cytokine Storm and Inflammation During Coronavirus Disease 19: Perspectives and Possible Therapeutic Approaches.
Mannino F; Bitto A; Irrera N
Front Pharmacol; 2020; 11():592169. PubMed ID: 33633566
[TBL] [Abstract][Full Text] [Related]
7. The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system.
Coperchini F; Chiovato L; Croce L; Magri F; Rotondi M
Cytokine Growth Factor Rev; 2020 Jun; 53():25-32. PubMed ID: 32446778
[TBL] [Abstract][Full Text] [Related]
8. Δ9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression.
Mohammed A; F K Alghetaa H; Miranda K; Wilson K; P Singh N; Cai G; Putluri N; Nagarkatti P; Nagarkatti M
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872332
[TBL] [Abstract][Full Text] [Related]
9. Specific cytokines in the inflammatory cytokine storm of patients with COVID-19-associated acute respiratory distress syndrome and extrapulmonary multiple-organ dysfunction.
Wang J; Yang X; Li Y; Huang JA; Jiang J; Su N
Virol J; 2021 Jun; 18(1):117. PubMed ID: 34088317
[TBL] [Abstract][Full Text] [Related]
10. Predisposition or Protection?: COVID-19 in a Patient on LVAD Support With HIV/AIDS.
Mahmood K; Rashed ER; Oliveros E; Chau VQ; Hermle T; Jacobs S; Lala A; Singhvi A; Parikh A; Pinney SP
JACC Case Rep; 2020 Jul; 2(9):1337-1341. PubMed ID: 32835275
[TBL] [Abstract][Full Text] [Related]
11. Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated with Coronavirus Disease-2019.
Nagarkatti P; Miranda K; Nagarkatti M
Front Pharmacol; 2020; 11():589438. PubMed ID: 33240092
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of Right Ventricular Longitudinal Strain in Patients With COVID-19.
Li Y; Li H; Zhu S; Xie Y; Wang B; He L; Zhang D; Zhang Y; Yuan H; Wu C; Sun W; Zhang Y; Li M; Cui L; Cai Y; Wang J; Yang Y; Lv Q; Zhang L; Xie M
JACC Cardiovasc Imaging; 2020 Nov; 13(11):2287-2299. PubMed ID: 32654963
[TBL] [Abstract][Full Text] [Related]
13. Outbreak of SARS-CoV-2: challenge for diagnosis and medical management in patients with left ventricular assist device: a case series.
Dan P; Birgit F; Matei M; Vuillemin V; Ottenin H; Maureira PJ; Vanhuyse F
Eur Heart J Case Rep; 2021 Mar; 5(3):ytaa447. PubMed ID: 33733044
[TBL] [Abstract][Full Text] [Related]
14. Acute Cor Pulmonale in COVID-19-Related ARDS: Improvement With Almitrine Infusion.
Huette P; Beyls C; Guilbart M; Haye G; Najid FZ; Mestan B; Roger PA; Dupont H; Abou-Arab O; Mahjoub Y
JACC Case Rep; 2020 Jul; 2(9):1311-1314. PubMed ID: 32835274
[TBL] [Abstract][Full Text] [Related]
15. Can Adenosine Fight COVID-19 Acute Respiratory Distress Syndrome?
Falcone C; Caracciolo M; Correale P; Macheda S; Vadalà EG; La Scala S; Tescione M; Danieli R; Ferrarelli A; Tarsitano MG; Romano L; De Lorenzo A
J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32967358
[TBL] [Abstract][Full Text] [Related]
16. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.
Agresti N; Lalezari JP; Amodeo PP; Mody K; Mosher SF; Seethamraju H; Kelly SA; Pourhassan NZ; Sudduth CD; Bovinet C; ElSharkawi AE; Patterson BK; Stephen R; Sacha JB; Wu HL; Gross SA; Dhody K
J Transl Autoimmun; 2021; 4():100083. PubMed ID: 33521616
[TBL] [Abstract][Full Text] [Related]
17. The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect.
Can A; Coskun H
Stem Cells Transl Med; 2020 Nov; 9(11):1287-1302. PubMed ID: 32779878
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of clinical and pathological features between severe acute respiratory syndrome and coronavirus disease 2019].
Zhang T; Sun LX; Feng RE
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Jun; 43(6):496-502. PubMed ID: 32241072
[TBL] [Abstract][Full Text] [Related]
19. Umbilical Cord-derived Mesenchymal Stem Cells for COVID-19 Patients with Acute Respiratory Distress Syndrome (ARDS).
Lanzoni G; Linetsky E; Correa D; Alvarez RA; Marttos A; Hirani K; Cayetano SM; Castro JG; Paidas MJ; Efantis Potter J; Xu X; Glassberg M; Tan J; Patel AN; Goldstein B; Kenyon NS; Baidal D; Alejandro R; Vianna R; Ruiz P; Caplan AI; Ricordi C
CellR4 Repair Replace Regen Reprogram; 2020; 8():. PubMed ID: 34164564
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases.
Tsuchiya A; Takeuchi S; Iwasawa T; Kumagai M; Sato T; Motegi S; Ishii Y; Koseki Y; Tomiyoshi K; Natsui K; Takeda N; Yoshida Y; Yamazaki F; Kojima Y; Watanabe Y; Kimura N; Tominaga K; Kamimura H; Takamura M; Terai S
Inflamm Regen; 2020; 40():14. PubMed ID: 32582401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
